Trial Profile
To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Apr 2024
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 21 Apr 2024 Status changed from active, no longer recruiting to completed.
- 17 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Jun 2012 Planned End Date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.